ARIA
Library/neuroprotection/Cerebrolysin (Injectable)

Cerebrolysin (Injectable)

Not FDA Approved✓ WADA Permitted
neuroprotectionClinical EvidenceNeurotrophic peptide mixture

NEUROPROTECTIVE peptide mixture derived from porcine brain proteins. Contains low-molecular-weight peptides and free amino acids. Approved in 40+ countries for stroke, TBI, and dementia. Not FDA-approved in the US but available through compounding. Mimics NGF and BDNF activity.

Confidence
82%
Half-Life ~hours
Cost ~$800/mo
Quick Reference
Routeintravenous / intramuscular
MechanismContains low-molecular-weight peptides that mimic NGF and BDNF activity. Promote...
Reviewed2026-06-08

Mechanism of Action

Contains low-molecular-weight peptides that mimic NGF and BDNF activity. Promotes neuronal survival, synaptic plasticity, and neurogenesis. Modulates neuroinflammation and supports brain repair mechanisms.

Dosing Protocol

IV: 10-30mL daily for 10-20 days (stroke/TBI protocol). IM: 5mL daily for cognitive support.

Adverse Effects

DizzinessHeadacheInjection site reactionsRare hypersensitivityFever (rare)

Contraindications

  • Severe renal impairment
  • Epilepsy (relative)
  • Pregnancy
  • Allergy to brain proteins

Storage

Refrigerate 2-8°C. Do not freeze.